Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss

v3.10.0.1
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Income Statement [Abstract]        
Revenue $ 26 $ 38
Cost of revenue 41 56
Gross loss (15) (18)
Operating expenses:        
Research and development 1,384 1,122 2,587 1,736
Sales and marketing 989 544 1,730 989
General and administrative 1,740 840 3,876 2,493
Total operating expenses 4,113 2,506 8,193 5,218
Operating loss (4,128) (2,506) (8,211) (5,218)
Warrant expense (3,156)
Loss on change in fair value of contingent royalty obligation (81) (69) (159) (134)
Finance income, net 30 29
Registration rights expense (900) (900)
Foreign currency loss (17) (5) (23) (9)
Loss before income taxes (4,196) (3,480) (11,520) (6,261)
Income tax expense
Net loss $ (4,196) $ (3,480) $ (11,520) $ (6,261)
Basic and diluted loss per common share (in dollars per share) $ (0.27) $ (0.33) $ (0.80) $ (0.62)
Weighted average number of common shares outstanding, basic and diluted (in shares) 15,645,755 10,488,647 14,318,272 10,175,157